MDT

86.5

+0.42%↑

A

115.44

+0.79%↑

VEEV

173.86

+0.6%↑

HQY

84.6

+1.48%↑

PHR.US

8.34

-0.6%↓

MDT

86.5

+0.42%↑

A

115.44

+0.79%↑

VEEV

173.86

+0.6%↑

HQY

84.6

+1.48%↑

PHR.US

8.34

-0.6%↓

MDT

86.5

+0.42%↑

A

115.44

+0.79%↑

VEEV

173.86

+0.6%↑

HQY

84.6

+1.48%↑

PHR.US

8.34

-0.6%↓

MDT

86.5

+0.42%↑

A

115.44

+0.79%↑

VEEV

173.86

+0.6%↑

HQY

84.6

+1.48%↑

PHR.US

8.34

-0.6%↓

MDT

86.5

+0.42%↑

A

115.44

+0.79%↑

VEEV

173.86

+0.6%↑

HQY

84.6

+1.48%↑

PHR.US

8.34

-0.6%↓

Search

Quidel Corp

Fechado

17.31 3.78

Visão Geral

Variação de preço das ações

24h

Atual

Mín

16.99

Máximo

17.31

Indicadores-chave

By Trading Economics

Rendimento

602M

-131M

Vendas

24M

724M

Margem de lucro

-18.062

Funcionários

6,500

Recomendações

By TipRanks

Recomendações

Neutro

Previsão para 12 meses

+78.26% upside

Dividendos

By Dow Jones

Próximos Ganhos

6 de mai. de 2026

Estatísticas de Mercado

By TradingEconomics

Capitalização de Mercado

-310M

899M

Abertura anterior

13.53

Fecho anterior

17.31

Quidel Corp Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

3 de abr. de 2026, 04:27 UTC

Notícias Principais

Singapore PM Warns That Fallout From Mideast War Could Outlast Conflict

3 de abr. de 2026, 20:50 UTC

Conversa de Mercado

Tech, Media & Telecom Roundup: Market Talk

3 de abr. de 2026, 18:30 UTC

Notícias Principais

An F15-E Just Went Down in Iran. What to Know About the $30 Million Jet. -- Barrons.com

3 de abr. de 2026, 18:14 UTC

Conversa de Mercado

Eli Lilly Seen as Possible GLP-1 Leader With New Pill Approval -- Market Talk

3 de abr. de 2026, 17:50 UTC

Conversa de Mercado

Microsoft's AI Development Will Weigh on Near-Term Azure Growth -- Market Talk

3 de abr. de 2026, 17:44 UTC

Aquisições, Fusões, Aquisições de Empresas

SBA Stock Just Had a Big Day. Why It's Suddenly Hot. -- Barrons.com

3 de abr. de 2026, 16:50 UTC

Notícias Principais

An F15-E Just Went Down in Iran. What to Know About the $90 Million Jet. -- Barrons.com

3 de abr. de 2026, 16:20 UTC

Conversa de Mercado

Tech, Media & Telecom Roundup: Market Talk

3 de abr. de 2026, 16:12 UTC

Ganhos

Oil Stocks Look Tapped Out. Why It's Time to Move Into Other Sectors. -- Barrons.com

3 de abr. de 2026, 15:56 UTC

Conversa de Mercado
Notícias Principais

Crypto Markets May Be Active Over Holiday Weekend -- Market Talk

3 de abr. de 2026, 15:56 UTC

Conversa de Mercado
Notícias Principais

Global Equities Roundup: Market Talk

3 de abr. de 2026, 15:56 UTC

Conversa de Mercado
Notícias Principais

Global Forex and Fixed Income Roundup: Market Talk

3 de abr. de 2026, 15:20 UTC

Notícias Principais

Berkshire, Travelers Join U.S. Plan to Insure Shippers in the Hormuz Strait -- Barrons.com

3 de abr. de 2026, 15:08 UTC

Aquisições, Fusões, Aquisições de Empresas

OpenAI Makes Surprise Media Acquisition Ahead of IPO. Why It Will Fail. -- Barrons.com

3 de abr. de 2026, 14:11 UTC

Conversa de Mercado
Notícias Principais

Oil Shock From War in Iran May Show Up In 2Q Job Growth Data -- Market Talk

3 de abr. de 2026, 12:56 UTC

Conversa de Mercado

Treasury Yields, Dollar Higher Following Robust March Hiring -- Market Talk

3 de abr. de 2026, 08:20 UTC

Conversa de Mercado

Tech, Media & Telecom Roundup: Market Talk

3 de abr. de 2026, 08:01 UTC

Conversa de Mercado

Global Equities Roundup: Market Talk

3 de abr. de 2026, 08:01 UTC

Conversa de Mercado

Meituan's Profitability Likely to Improve This Year -- Market Talk

3 de abr. de 2026, 07:45 UTC

Conversa de Mercado

LG Electronics Could Post Above-Consensus 1Q Earnings -- Market Talk

3 de abr. de 2026, 06:17 UTC

Conversa de Mercado

Naver Likely to Post Below-Consensus 1Q Earnings -- Market Talk

3 de abr. de 2026, 06:17 UTC

Conversa de Mercado

Global Equities Roundup: Market Talk

3 de abr. de 2026, 04:33 UTC

Conversa de Mercado

China Merchants Port Earnings Likely to Recover This Year -- Market Talk

3 de abr. de 2026, 04:33 UTC

Conversa de Mercado

Global Equities Roundup: Market Talk

3 de abr. de 2026, 04:15 UTC

Conversa de Mercado

Global Commodities Roundup: Market Talk

3 de abr. de 2026, 04:01 UTC

Conversa de Mercado

Posco Holdings 1Q Earnings Could Fall Short of Expectations -- Market Talk

3 de abr. de 2026, 02:01 UTC

Conversa de Mercado

India Consumer-Staple Companies Likely to Post Broadly Steady 4Q Results -- Market Talk

3 de abr. de 2026, 01:59 UTC

Conversa de Mercado

Sea's Shopee E-Commerce Platform Likely in Reinvestment Phase -- Market Talk

3 de abr. de 2026, 01:44 UTC

Conversa de Mercado

Samsung Likely to Report Record Quarterly Earnings in 2026 -- Market Talk

3 de abr. de 2026, 01:22 UTC

Conversa de Mercado

Dollar Could Hit 160 Yen in Thin Holiday Trading -- Market Talk

Comparação entre Pares

Variação de preço

Quidel Corp Previsão

Preço-alvo

By TipRanks

78.26% parte superior

Previsão para 12 meses

Média 30.75 USD  78.26%

Máximo 38 USD

Mínimo 25 USD

Com base em 5 analistas de Wall Street que oferecem metas de preço de 12 meses para Quidel Corp - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Neutro

5 ratings

1

Comprar

3

Manter

1

Vender

Informação Financeira

Custos administrativos e de venda

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

Resultado Operacional

$

Sobre Quidel Corp

QuidelOrtho Corporation provides diagnostic testing solutions. The company operates through Labs, Transfusion Medicine, Point-of-Care, and Molecular Diagnostics business units. The Labs business unit provides clinical chemistry laboratory instruments and tests that measure target chemicals in bodily fluids for the evaluation of health and the clinical management of patients; immunoassay laboratory instruments and tests, which measure proteins as they act as antigens in the spread of disease, antibodies in the immune response spurred by disease, or markers of proper organ function and health; testing products to detect and monitor disease progression across a spectrum of therapeutic areas; and specialized diagnostic solutions. The Transfusion Medicine business unit offers immunohematology instruments and tests used for blood typing to ensure patient-donor compatibility in blood transfusions; and donor screening instruments and tests used for blood and plasma screening for infectious diseases. The Point-of-Care business unit provides instruments and tests to provide rapid results across a continuum of point-of-care settings. The Molecular Diagnostics business unit offers polymerase chain reaction thermocyclers; amplification systems; and sample-to-result molecular instruments and tests for syndromic infectious disease diagnostics. The company sells its products directly to end users through a direct sales force; and through a network of distributors for professional use in physician offices, hospitals, clinical laboratories, reference laboratories, urgent care clinics, universities, retail clinics, pharmacies, wellness screening centers, blood banks, and donor centers, as well as for individual, non-professional, and over-the-counter use. It operates in North America, Europe, the Middle East, Africa, China, and internationally. The company was incorporated in 1979 and is headquartered in San Diego, California.
help-icon Live chat